Alnylam Pharmaceuticals
ALNY
#563
Rank
ยฃ32.94 B
Marketcap
ยฃ248.41
Share price
0.51%
Change (1 day)
28.57%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Alnylam Pharmaceuticals (ALNY) - Total assets

Total assets on the balance sheet as of December 2025 : ยฃ3.70 Billion

According to Alnylam Pharmaceuticals 's latest financial reports the company's total assets are ยฃ3.70 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Alnylam Pharmaceuticals - Total assets on balance sheet (from 2003 to 2025)

Total assets by year

Year Total assets Change
2025-12-31ยฃ3.68 B9.15%
2024-12-31ยฃ3.37 B12.39%
2023-12-31ยฃ3.00 B2.55%
2022-12-31ยฃ2.93 B8.61%
2021-12-31ยฃ2.69 B7.98%
2020-12-31ยฃ2.49 B36.85%
2019-12-31ยฃ1.82 B47.23%
2018-12-31ยฃ1.24 B-15.94%
2017-12-31ยฃ1.47 B44.21%
2016-12-31ยฃ1.02 B9.39%
2015-12-31ยฃ0.93 B34.93%
2014-12-31ยฃ0.69 B171.99%
2013-12-31ยฃ0.25 B43.32%
2012-12-31ยฃ0.17 B-1.92%
2011-12-31ยฃ0.18 B-28.8%
2010-12-31ยฃ0.25 B-14.36%
2009-12-31ยฃ0.29 B-21.4%
2008-12-31ยฃ0.37 B52.26%
2007-12-31ยฃ0.24 B102.86%
2006-12-31ยฃ0.12 B114.85%
2005-12-31ยฃ57.03 M65.62%
2004-12-31ยฃ34.43 M75.08%
2003-12-31ยฃ19.66 M95.74%
2002-12-31ยฃ10.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Novartis
NVS
ยฃ82.78 B 2,134.02%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
ยฃ113.65 B 2,967.13%๐Ÿ‡ซ๐Ÿ‡ท France
Regeneron Pharmaceuticals
REGN
ยฃ30.26 B 716.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ2.60 B-29.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
ยฃ55.83 M-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
ยฃ1.48 B-59.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ30.40 B 720.49%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Arrowhead Pharmaceuticals
ARWR
ยฃ1.19 B-67.70%๐Ÿ‡บ๐Ÿ‡ธ USA